News

Caretaker Medical Receives Inaugural Healthcare Tech Innovation Award and $200,000 Grant from Medical Society of D.C.

Caretaker Medical is honored to announce it has been awarded the Healthcare Technology Innovation Award, along with a $200,000 grant, from the Medical Society of the District of Columbia (MSDC) at the 5th annual Capital Healthcare Honors Gala. This prestigious award, presented on March 26, 2025, recognizes Caretaker Medical’s groundbreaking work in advancing wireless patient monitoring with its VitalStream platform.

The award, supported by a grant from The Institute for Technology in Healthcare, commemorates the legacy of Dr. Cesar A. C. Caceres, an esteemed medical professional dedicated to the application of technology to solve healthcare challenges. Dr. Caceres founded the Institute for Technology in Healthcare and was recognized for his pioneering work in computer-electrocardiographic interpretive systems.

“We are delighted to celebrate the memory and achievements of Dr. Caceres by presenting Caretaker Medical with this inaugural award,” said Matthew Lecuyer, MD, Healthy Physician Foundation board chair. “As technology improves patient care and physician wellbeing, this award connects the achievements of the past with the promise of the future.”

Caretaker Medical’s CEO, Jeff Pompeo, accepted the award on behalf of the company, expressing gratitude for the recognition of their commitment to improving patient care and physician health. “This award validates our dedication to providing patients and physicians with a much-needed wearable, continuous blood pressure monitoring solution,” said Pompeo.

VitalStream, Caretaker Medical’s US Food and Drug Administration-cleared wearable monitor, merges clinical accuracy with a wire-free, comfortable patient experience. The $200,000 grant will support the expansion of this innovative platform, which provides continuous blood pressure and hemodynamic monitoring.

The technology has demonstrated versatility in routine care and crisis response, proving invaluable in applications such as maternal health monitoring, perioperative recovery, and during the recent IV fluid shortages caused by Hurricane Helene. In these challenging times, VitalStream has helped healthcare providers maintain continuous blood pressure monitoring, ensuring patient safety and optimizing fluid management.

“VitalStream offers significant advantages for patients and providers in routine conditions, as well as unexpected and demanding circumstances,” said Johnny Mann, vice president of sales and marketing at Caretaker Medical. “Our technology can help ensure patient safety and optimize fluid management during some of the most challenging times.”

Caretaker Medical extends its deepest gratitude to the MSDC and The Institute for Technology in Healthcare for this honor and for their tireless efforts to advance healthcare in the Nation’s Capital Region and beyond.

Learn more here.

Recent News

04/24/2026

Skyphos Technologies Has Been Awarded its Second U.S. Patent

Skyphos Technologies has been awarded its second U.S. patent, adding to a growing intellectual property portfolio that now includes nearly a dozen patent applications in process around the world. This latest patent secures core technologies and methods that allow micro-scale parts to be produced in seconds, at throughputs designed to exceed legacy manufacturing such as

04/23/2026

CollectiveMinds LLC Places Keith Meadors as Chief Commercial Officer at Genova Diagnostics

CollectiveMinds LLC, a leading executive search firm specializing in life sciences and healthcare, today announced the successful placement of Keith Meadors as Chief Commercial Officer of Genova Diagnostics, a pioneer in advanced diagnostic testing. The appointment marks another milestone for CollectiveMinds in connecting exceptional leadership talent with high-growth organizations across the diagnostics and life sciences

04/22/2026

RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system

RIVANNA®, developer of AI-enabled clinical decision-support solutions, announced that it has expanded its clinical studies evaluating Accuro® XV, the company’s musculoskeletal imaging system, from two to eight sites nationwide. This expansion follows execution of a funding option by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response